Christopher Erickson

Christopher Erickson

Auto-generated profile, based on publicly available information

Christopher Erickson

Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2024 in Blood
Verified
Journal Article
Closed access
PDF file
TNTravis Nemkov
Travis Nemkov
DSDaniel Stephenson
Daniel Stephenson
CEChristopher Erickson
Christopher Erickson
MDMonika Dzieciatkowska
Monika Dzieciatkowska
AKAlicia Key
Alicia Key
Angelo D'AlessandroAngelo D'Alessandro
Angelo D'Alessandro
In the field of transfusion medicine, the clinical relevance of the metabolic markers of the red blood cell (RBC) storage lesion is incompletely understood. Here, we performed metabolomics of RBC units from 643 donors enrolled in the Recipient Epidemiology and Donor Evaluation Study, REDS RBC Omics. These units were tested on storage days 10, 23, and 42 for a total of 1929 samples and also characterized for end-of-storage hemolytic propensity after oxidative and osmotic insults. Our results indicate that the metabolic markers of the storage lesion poorly correlated with hemolytic propensity. In contrast, kynurenine was not affected by storage duration and was identified as the top predictor of osmotic fragility. RBC kynurenine levels were affected by donor age and body mass index and were reproducible within the same donor across multiple donations from 2 to 12 months apart. To delve into the genetic underpinnings of kynurenine levels in stored RBCs, we thus tested kynurenine levels in stored RBCs on day 42 from 13 091 donors from the REDS RBC Omics study, a population that was also genotyped for 879 000 single nucleotide polymorphisms. Through a metabolite quantitative trait loci analysis, we identified polymorphisms in SLC7A5, ATXN2, and a series of rate-limiting enzymes (eg, kynurenine monooxygenase, indoleamine 2,3-dioxygenase, and tryptophan dioxygenase) in the kynurenine pathway as critical factors affecting RBC kynurenine levels. By interrogating a donor-recipient linkage vein-to-vein database, we then report that SLC7A5 polymorphisms are also associated with changes in hemoglobin and bilirubin levels, suggestive of in vivo hemolysis in 4470 individuals who were critically ill and receiving single-unit transfusions.

25 November 2022 in Bioactive Materials
Verified
Journal Article
Open access
Ming PeiMing Pei
Ming Pei
YPYixuan Amy Pei
Yixuan Amy Pei
SZSheng Zhou
Sheng Zhou
EMElmira Mikaeiliagah
Elmira Mikaeiliagah
CEChristopher Erickson
Christopher Erickson
Gangqing HuGangqing Hu
Gangqing Hu
Articular cartilage has a limited capacity to self-heal once damaged. Tissue-specific stem cells are a solution for cartilage regeneration; however, ex vivo expansion resulting in cell senescence remains a challenge as a large quantity of high-quality tissue-specific stem cells are needed for cartilage regeneration. Our previous report demonstrated that decellularized extracellular matrix (dECM) deposited by human synovium-derived stem cells (SDSCs), adipose-derived stem cells (ADSCs), urine-derived stem cells (UDSCs), or dermal fibroblasts (DFs) provided an ex vivo solution to rejuvenate human SDSCs in proliferation and chondrogenic potential, particularly for dECM deposited by UDSCs. To make the cell-derived dECM (C-dECM) approach applicable clinically, in this study, we evaluated ex vivo rejuvenation of rabbit infrapatellar fat pad-derived stem cells (IPFSCs), an easily accessible alternative for SDSCs, by the abovementioned C-dECMs, in vivo application for functional cartilage repair in a rabbit osteochondral defect model, and potential cellular and molecular mechanisms underlying this rejuvenation. We found that C-dECM rejuvenation promoted rabbit IPFSCs' cartilage engineering and functional regeneration in both ex vivo and in vivo models, particularly for the dECM deposited by UDSCs, which was further confirmed by proteomics data. RNA-Seq analysis indicated that both mesenchymal-epithelial transition (MET) and inflammation-mediated macrophage activation and polarization are potentially involved in the C-dECM-mediated promotion of IPFSCs’ chondrogenic capacity, which needs further investigation.

12 November 2020 in Journal of Orthopaedic Research
Verified
Journal Article
Closed access
PDF file
CEChristopher B. Erickson
Christopher B. Erickson
JNJake P. Newsom
Jake P. Newsom
NFNathan A. Fletcher
Nathan A. Fletcher
YYYangyi Yu
Yangyi Yu
FRFrancisco Rodriguez‐Fontan
Francisco Rodriguez‐Fontan
KPKarin A. Payne
Karin A. Payne

1 December 2019 in Tissue Engineering Part C: Methods
Verified
Journal Article
Open access
YYYangyi Yu
Yangyi Yu
FRFrancisco Rodriguez-Fontan
Francisco Rodriguez-Fontan
KEKevin Eckstein
Kevin Eckstein
AMArchish Muralidharan
Archish Muralidharan
AUAsais Camila Uzcategui
Asais Camila Uzcategui
KPKarin A. Payne
Karin A. Payne
Physeal injuries can lead to bony repair tissue formation, known as a bony bar. This can result in growth arrest or angular deformity, which is devastating for children who have not yet reached their full height. Current clinical treatment involves resecting the bony bar and replacing it with a fat graft to prevent further bone formation and growth disturbance, but these treatments frequently fail to do so and require additional interventions. Novel treatments that could prevent bone formation but also regenerate the injured physeal cartilage and restore normal bone elongation are warranted. To test the efficacy of these treatments, animal models that emulate human physeal injury are necessary. The rabbit model of physeal injury quickly establishes a bony bar, which can then be resected to test new treatments. Although numerous rabbit models have been reported, they vary in terms of size and location of the injury, tools used to create the injury, and methods to assess the repair tissue, making comparisons between studies difficult. The study presented here provides a detailed method to create a rabbit model of proximal tibia physeal injury using a two-stage procedure. The first procedure involves unilateral removal of 25% of the physis in a 6-week-old New Zealand white rabbit. This consistently leads to a bony bar, significant limb length discrepancy, and angular deformity within 3 weeks. The second surgical procedure involves bony bar resection and treatment. In this study, we tested the implantation of a fat graft and a photopolymerizable hydrogel as a proof of concept that injectable materials could be delivered into this type of injury. At 8 weeks post-treatment, we measured limb length, tibial angle, and performed imaging and histology of the repair tissue. By providing a detailed, easy to reproduce methodology to perform the physeal injury and test novel treatments after bony bar resection, comparisons between studies can be made and facilitate translation of promising therapies toward clinical use. Impact Statement: This study provides details to create a rabbit model of physeal injury that can facilitate comparisons between studies and test novel regenerative medicine approaches. Furthermore, this model mimics the human, clinical situation that requires a bony bar resection followed by treatment. In addition, identification of a suitable treatment can be seen in the correction of the growth deformity, allowing this model to facilitate the development of novel physeal cartilage regenerative medicine approaches.

11 February 2026 in Science Translational Medicine
Verified
Journal Article
Closed access
MCMitchell J. Cohen
Mitchell J. Cohen
CEChristopher B. Erickson
Christopher B. Erickson
ILIan S. Lacroix
Ian S. Lacroix
MDMargot Debot
Margot Debot
MDMonika Dzieciatkowska
Monika Dzieciatkowska
KHKirk C. Hansen
Kirk C. Hansen
Understanding the complexity of trauma-induced thromboinflammation necessitates data-driven approaches. We hypothesized that longitudinal plasma profiling could reveal underlying differences in patients with injury who present with similar clinical characteristics but ultimately have different outcomes. Here, we performed multiomic analyses of longitudinal plasma samples from a clinical trial of patients with traumatic injury to identify molecular endotypes and trajectories that were associated with patient outcomes. The pathophysiologic states of patients with trauma were defined by the longitudinal proteomic and metabolomic plasma profiles from a diverse cohort. Then, patients were endotyped according to their longitudinal trajectories through trauma omic states, and injury patterns and outcomes were compared. We identified endotypes associated with divergent clinical outcomes despite similar injury patterns at presentation. Organ failure and time spent in the intensive care unit (ICU) were predicted with high accuracy using omic markers. Patients who presented with evidence of elevated proteasome activation, catabolism, and superoxide formation were vulnerable to heart failure, lung failure, and acute lung injury, respectively. In addition, omic markers of increased hypoxia, RBC lysis, and hydrolase activity better fit mortality and ICU time compared with injury covariates, while providing biological insight. Injury and outcome patterns persisted in a validation trauma cohort after endotype assignment at a single, early time point. These data align with the understanding that patients with trauma may experience markedly different biological responses and outcomes despite similar clinical presentations. We suggest that mapping patient trajectories through biological injury states could provide a framework for personalized patient treatment after trauma.

16 July 2024 in Blood Vessels, Thrombosis & Hemostasis
Verified
Journal Article
Open access
MDMargot DeBot
Margot DeBot
CEChristopher Erickson
Christopher Erickson
TSTerry Schaid
Terry Schaid
ILIan LaCroix
Ian LaCroix
EMErnest Moore
Ernest Moore
KHKirk C. Hansen
Kirk C. Hansen
• Fibrinogen activity decreases rapidly after injury. • Fibrinogen repletion increases quantity but does not improve activity in injured patients.